Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hepatitis A virus: from discovery to vaccines.

Martin A, Lemon SM.

Hepatology. 2006 Feb;43(2 Suppl 1):S164-72. Review.

PMID:
16447259
2.

[Hepatitis A virus infection. A review].

Siegl G.

Praxis (Bern 1994). 2003 Oct 1;92(40):1659-73. Review. German.

PMID:
14579471
3.

[Structure of HAV particle].

Shimoike T.

Nihon Rinsho. 2004 Aug;62 Suppl 8:423-7. Review. Japanese. No abstract available.

PMID:
15453359
4.

Genetic variability and molecular evolution of hepatitis A virus.

Cristina J, Costa-Mattioli M.

Virus Res. 2007 Aug;127(2):151-7. Epub 2007 Feb 27. Review.

PMID:
17328982
5.

Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?

Villar LM, de Melo MM, Calado IA, de Almeida AJ, Lampe E, Gaspar AM.

J Gastroenterol Hepatol. 2009 Feb;24(2):238-42. doi: 10.1111/j.1440-1746.2008.05575.x.

PMID:
19215334
6.

Hepatitis A virus evolution and the potential emergence of new variants escaping the presently available vaccines.

Pintó RM, D'Andrea L, Pérez-Rodriguez FJ, Costafreda MI, Ribes E, Guix S, Bosch A.

Future Microbiol. 2012 Mar;7(3):331-46. doi: 10.2217/fmb.12.5. Review.

PMID:
22393888
7.

Epaxal: a virosomal vaccine to prevent hepatitis A infection.

Bovier PA.

Expert Rev Vaccines. 2008 Oct;7(8):1141-50. doi: 10.1586/14760584.7.8.1141. Review.

PMID:
18844588
8.

Live attenuated hepatitis A vaccines developed in China.

Xu ZY, Wang XY.

Hum Vaccin Immunother. 2014;10(3):659-66. Epub 2013 Nov 26. Review.

9.

[Vaccination against hepatitis A].

Balli F, Di Biase AR, Viola L.

Pediatr Med Chir. 1996 May-Jun;18(3):259-62. Review. Italian.

PMID:
8966125
10.

Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series.

Raczniak GA, Bulkow LR, Bruce MG, Zanis CL, Baum RL, Snowball MM, Byrd KK, Sharapov UM, Hennessy TW, McMahon BJ.

J Infect Dis. 2013 Feb 1;207(3):493-6. doi: 10.1093/infdis/jis710. Epub 2012 Nov 29.

11.

[Horizontal transmission of live attenuated hepatitis A vaccine virus].

Huang X, Cao Y, Tan S.

Zhonghua Yi Xue Za Zhi. 2001 Apr 25;81(8):465-7. Chinese.

PMID:
11798919
12.

Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.

Vidor E.

J Comp Pathol. 2007 Jul;137 Suppl 1:S42-5. Epub 2007 Jun 6. Review.

PMID:
17555761
13.
14.
15.

Hepatitis A vaccines.

Nothdurft HD.

Expert Rev Vaccines. 2008 Jul;7(5):535-45. doi: 10.1586/14760584.7.5.535. Review.

PMID:
18564009
16.

Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine.

Iwarson S, Lindh M, Widerström L.

J Travel Med. 2004 Mar-Apr;11(2):120-1. No abstract available.

17.

Comparison of Immunogenicity Between Inactivated and Live Attenuated Hepatitis A Vaccines Among Young Adults: A 3-Year Follow-up Study.

Liu XE, Chen HY, Liao Z, Zhou Y, Wen H, Peng S, Liu Y, Li R, Li J, Zhuang H.

J Infect Dis. 2015 Oct 15;212(8):1232-6. doi: 10.1093/infdis/jiv213. Epub 2015 May 12.

PMID:
25969561
18.

Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Irving GJ, Holden J, Yang R, Pope D.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009051. doi: 10.1002/14651858.CD009051.pub2. Review.

PMID:
22786522
19.

Supplemental Content

Support Center